Amgen (AMGN) Accumulated Expenses (2016 - 2025)
Historic Accumulated Expenses for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $16.8 billion.
- Amgen's Accumulated Expenses rose 1490.32% to $16.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.8 billion, marking a year-over-year increase of 1490.32%. This contributed to the annual value of $17.6 billion for FY2024, which is 1485.77% up from last year.
- Latest data reveals that Amgen reported Accumulated Expenses of $16.8 billion as of Q3 2025, which was up 1490.32% from $15.0 billion recorded in Q2 2025.
- Over the past 5 years, Amgen's Accumulated Expenses peaked at $17.6 billion during Q4 2024, and registered a low of $9.0 billion during Q2 2021.
- Over the past 5 years, Amgen's median Accumulated Expenses value was $13.7 billion (recorded in 2023), while the average stood at $13.1 billion.
- Its Accumulated Expenses has fluctuated over the past 5 years, first crashed by 321.05% in 2021, then surged by 3009.01% in 2023.
- Over the past 5 years, Amgen's Accumulated Expenses (Quarter) stood at $10.7 billion in 2021, then increased by 16.71% to $12.5 billion in 2022, then increased by 22.64% to $15.4 billion in 2023, then increased by 14.86% to $17.6 billion in 2024, then decreased by 4.77% to $16.8 billion in 2025.
- Its last three reported values are $16.8 billion in Q3 2025, $15.0 billion for Q2 2025, and $17.2 billion during Q1 2025.